MGX earnings
Metagenomi Therapeutics (MGX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- MGX beat EPS estimates in 6 of its last 8 reports.
MGX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 10, 2026 | -0.56 | -0.64 | 12.43% | $2.18M |
| Q2 2026 | Aug 10, 2026 | -0.73 | – | – | -$257.00K |
| Q1 2026 | May 11, 2026 | -0.61 | – | – | $1.25M |
| Q4 2025 | Mar 5, 2026 | -0.60 | -0.58 | -3.45% | $3.91M |
| Q3 2025 | Nov 11, 2025 | -0.55 | -0.60 | 8.33% | $8.66M |
| Q2 2025 | Aug 12, 2025 | -0.54 | -0.68 | 20.59% | $8.51M |
| Q1 2025 | May 13, 2025 | -0.68 | – | – | $4.13M |
| Q4 2024 | Mar 17, 2025 | -0.63 | -0.75 | 15.88% | $9.61M |
| Q3 2024 | Nov 13, 2024 | -0.45 | -0.70 | 35.71% | $11.51M |
| Q2 2024 | Aug 14, 2024 | -0.29 | -0.59 | 50.85% | $20.01M |
| Q1 2024 | May 14, 2024 | -1.19 | -0.95 | -25.26% | $11.16M |